Transport and inhibition mechanism for VMAT2-mediated synaptic vesicle loading of monoamines
Open Access
- 2 January 2024
- journal article
- research article
- Published by Springer Nature in Cell Research
- Vol. 34 (1) , 47-57
Abstract
Monoamine neurotransmitters such as serotonin and dopamine are loaded by vesicular monoamine transporter 2 (VMAT2) into synaptic vesicles for storage and subsequent release in neurons. Impaired VMAT2 function underlies various neuropsychiatric diseases. VMAT2 inhibitors reserpine and tetrabenazine are used to treat hypertension, movement disorders associated with Huntington’s Disease and Tardive Dyskinesia. Despite its physiological and pharmacological significance, the structural basis underlying VMAT2 substrate recognition and its inhibition by various inhibitors remains unknown. Here we present cryo-EM structures of human apo VMAT2 in addition to states bound to serotonin, tetrabenazine, and reserpine. These structures collectively capture three states, namely the lumen-facing, occluded, and cytosol-facing conformations. Notably, tetrabenazine induces a substantial rearrangement of TM2 and TM7, extending beyond the typical rocker-switch movement. These functionally dynamic snapshots, complemented by biochemical analysis, unveil the essential components responsible for ligand recognition, elucidate the proton-driven exchange cycle, and provide a framework to design improved pharmaceutics targeting VMAT2.Keywords
Funding Information
- National Natural Science Foundation of China (32171194, 32371256, 82225025, 32071197)
- China Postdoctoral Science Foundation (2022M720805)
- Ministry of Science and Technology of the People’s Republic of China (2020YFA0509600)
This publication has 61 references indexed in Scilit:
- Brain Dopamine–Serotonin Vesicular Transport Disease and Its TreatmentNew England Journal of Medicine, 2013
- VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuseAnnals of the New York Academy of Sciences, 2011
- PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKaPredictionsJournal of Chemical Theory and Computation, 2011
- Vesicular Monoamine Transporters (VMATs) in Adrenal Chromaffin Cells: Stress-Triggered Induction of VMAT2 and Expression in Epinephrine Synthesizing CellsCellular and Molecular Neurobiology, 2010
- Features and development of CootActa Crystallographica Section D Structural Biology, 2010
- PHENIX: a comprehensive Python-based system for macromolecular structure solutionActa Crystallographica Section D Structural Biology, 2010
- MolProbity: all-atom structure validation for macromolecular crystallographyActa Crystallographica Section D Structural Biology, 2009
- Canonical sampling through velocity rescalingThe Journal of Chemical Physics, 2007
- A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporterCell, 1992
- Inhibition of Norepinephrine Transport and Reserpine Binding by Reserpine DerivativesJournal of Neurochemistry, 1987